RAFFA WEALTH MANAGEMENT, LLC’s Agios Pharmaceuticals AGIO Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32	Closed	-$1.08K	–	1594
2026 Q1	$1.08K	Hold	32	–	–	﹤0.01%	926
2025 Q4	$871	Hold	32	–	–	﹤0.01%	953
2025 Q3	$1.28K	Hold	32	–	–	﹤0.01%	833
2025 Q2	$1.06K	Hold	32	–	–	﹤0.01%	854
2025 Q1	$938	Hold	32	–	–	﹤0.01%	848
2024 Q4	$1.05K	Hold	32	–	–	﹤0.01%	862
2024 Q3	$1.42K	Hold	32	–	–	﹤0.01%	728
2024 Q2	$1.38K	Hold	32	–	–	﹤0.01%	808
2024 Q1	$936	Hold	32	–	–	﹤0.01%	908
2023 Q4	$713	Hold	32	–	–	﹤0.01%	908
2023 Q3	$792	Hold	32	–	–	﹤0.01%	847
2023 Q2	$906	Hold	32	–	–	﹤0.01%	824
2023 Q1	$735	Hold	32	–	–	﹤0.01%	880
2022 Q4	$899	Hold	32	–	–	﹤0.01%	810
2022 Q3	$905	Hold	32	–	–	﹤0.01%	834
2022 Q2	$709	Hold	32	–	–	﹤0.01%	926
2022 Q1	$932	Hold	32	–	–	﹤0.01%	892
2021 Q4	$1.05K	Hold	32	–	–	﹤0.01%	846
2021 Q3	$1.48K	Hold	32	–	–	﹤0.01%	696
2021 Q2	$1.76K	Hold	32	–	–	﹤0.01%	659
2021 Q1	$1.65K	Hold	32	–	–	﹤0.01%	690
2020 Q4	$1.39K	Hold	32	–	–	﹤0.01%	654
2020 Q3	$1.12K	Hold	32	–	–	﹤0.01%	638
2020 Q2	$1.71K	Hold	32	–	–	﹤0.01%	511
2020 Q1	$1.14K	Hold	32	–	–	﹤0.01%	552
2019 Q4	$1.53K	Buy	+32	New	+$1.21K	﹤0.01%	465
2016 Q3	–	Sell	-5	Closed	-$209	–	871
2016 Q2	$209	Hold	5	–	–	﹤0.01%	849
2016 Q1	$203	Hold	5	–	–	﹤0.01%	828
2015 Q4	$325	Hold	5	–	–	﹤0.01%	792
2015 Q3	$353	Hold	5	–	–	﹤0.01%	777
2015 Q2	$556	Hold	5	–	–	﹤0.01%	653
2015 Q1	$472	Buy	+5	New	+$560	﹤0.01%	737

Other funds holding AGIO

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's AGIO Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 32 shares — an estimated $1.08K sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in AGIO in Q1 2015 and held it in 32 quarters. The position peaked at $1.76K in Q2 2021. 35 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
RAFFA WEALTH MANAGEMENT, LLC sold 32 Agios Pharmaceuticals shares in Q2 2026, an estimated $1.08K.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Agios Pharmaceuticals in Q1 2015 and held it in 32 quarters.
RAFFA WEALTH MANAGEMENT, LLC's Agios Pharmaceuticals position peaked at $1.76K in Q2 2021.
35 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.